Latest Product Development News

Page 7 of 109
FortifAI has emerged from its first year as an AI infrastructure company with $20.4 million in cash, but a $29 million statutory loss and sharply lower gaming revenue. The company now needs to turn NOL8’s early testing and partnerships into commercial adoption before its cash-backed growth strategy faces a harder test.
Sophie Babbage
Sophie Babbage
30 Sept 2026
Norwood Systems delivered higher revenue, record customer receipts and a sharp reduction in operating cash outflow in FY2026. But the ASX-listed AI voice company remains loss-making, cash-light and subject to a material going-concern uncertainty.
Victor Sage
Victor Sage
30 Sept 2026
CONNEQT Health delivered sharp FY26 revenue growth and reduced its statutory loss as Pulse sales and clinical subscriptions expanded. But the ASX-listed medtech group ended the year with negative net assets, heavy cash burn and a material uncertainty over its ability to continue as a going concern.
Victor Sage
Victor Sage
30 Sept 2026
Decidr AI Industries delivered 99% revenue growth and a A$13.6 million annualised exit rate in FY26, but the company’s A$32.4 million loss and auditor-highlighted going concern uncertainty put funding at the centre of its next chapter. Management is targeting A$5 million in annualised savings while seeking to convert early AI deployments into recurring revenue.
Victor Sage
Victor Sage
30 Sept 2026
Rectifier Technologies has warned of a material uncertainty over its ability to continue as a going concern after revenue fell 41% and its annual loss widened to $6.39 million. An auditor-highlighted liquidity risk now sits alongside a $13 million order book and new EV charging products under development.
Victor Sage
Victor Sage
30 Sept 2026
Papyrus Australia has produced a second batch of TBS board samples, expanded pulp capacity in Adelaide and secured additional funding as it moves towards commercial supply. The progress comes with testing still incomplete and an estimated 4.87 months of funding available.
Victor Sage
Victor Sage
30 Sept 2026
AI-Media has set FY27 targets for ARR of $44 million to $46 million and announced an on-market buy-back of up to 20.8 million shares. The combination gives shareholders a clearer scorecard for growth and capital allocation, but neither the guidance nor the full buy-back is guaranteed.
Sophie Babbage
Sophie Babbage
30 Sept 2026
AnteoTech has received $1.905 million from the Australian R&D Tax Incentive, providing fresh cash for its battery materials and life sciences commercialisation efforts. The rebate relates to eligible research conducted during the 2026 financial year.
Sophie Babbage
Sophie Babbage
29 Sept 2026
SportsHero’s FY2026 revenue rose above A$1 million as HeroPlay gained traction through Southeast Asian telco partnerships. But the company remains deeply loss-making, burned A$1.9 million in operating cash and carries a material uncertainty over its ability to continue as a going concern.
Victor Sage
Victor Sage
29 Sept 2026
EMVision Medical Devices has received a $4.3 million R&D tax refund, adding non-dilutive funding as it progresses clinical work on its emu™ and First Responder devices. The cash arrives against a last reported cash balance of $17.1 million and $4.6 million in remaining grant funding at 30 June 2026.
Victor Sage
Victor Sage
28 Sept 2026
Nexsen has proposed a 50:50 joint venture with FlashDx Shenzhen to develop and commercialise an enhanced molecular Group B Streptococcus test, using an existing CE-marked platform as its starting point. The proposed venture could shorten Nexsen’s path into hospital and intrapartum testing across Asia-Pacific, but the term sheet remains non-binding and regulatory work is still ahead.
Victor Sage
Victor Sage
25 Sept 2026
Me Today reported a NZ$2.66 million FY26 profit, but the result was dominated by a NZ$4.12 million gain from losing control of King Honey. The remaining business grew revenue and improved its operating loss, yet continued to consume cash and will rely on October warrant funding.
Victor Sage
Victor Sage
25 Sept 2026

Browse the archive

Full archive